REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Oncobiologico CIA Ltda (Ecuador)

Main Activities: Pharmacies and Drug Stores
Full name: Oncobiologico CIA Ltda Profile Updated: February 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Oncobiologico CIA Ltda is a company based in Ecuador, with its head office in Cuenca. It operates in the Pharmacies and Drug Stores industry. It was established on February 07, 2007. Oncobiologico CIA Ltda currently employs 13 (2024) people. From the latest financial highlights, Oncobiologico CIA Ltda reported a net sales revenue increase of 33.41% in 2024. Over the same period, its total assets grew by 25.63%. The enterprise’s net profit margin increased by 0.41% in 2024.

Headquarters
Alfonso Moreno Mora 3-65
Cuenca; Azuay;

Contact Details: Purchase the Oncobiologico CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Oncobiologico CIA Ltda report to view the information.
Registered Capital:
Purchase the Oncobiologico CIA Ltda report to view the information.
Financial Auditors:
Purchase the Oncobiologico CIA Ltda report to view the information.
Incorporation Date:
February 07, 2007
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
30%
Purchase this report to view the information.
30%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Oncobiologico CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
33.41%▲
Total operating revenue
33.41%▲
Operating profit (EBIT)
46.49%▲
EBITDA
44.03%▲
Net Profit (Loss) for the Period
45.25%▲
Total assets
25.63%▲
Total equity
8.1%▲
Operating Profit Margin (ROS)
0.76%▲
Net Profit Margin
0.41%▲
Return on Equity (ROE)
8.22%▲
Debt to Equity Ratio
-106.83%▼
Quick Ratio
0.01%▲
Cash Ratio
0.01%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo